Key Medicine Shortages – November 2022
Monthly Update
-
Dioralyte® oral rehydration sachets – these are expected to be in limited supply until late December 2022.
Please refer to the Medicine Supply Notification on StaffNet for information on alternative options, actions required by clinicians and other supporting information.
-
Prochlorperazine (Stemetil®) 5mg/5ml Syrup – all batches of this syrup have been recalled as a precautionary measure due to the identification of N-nitrosomethylphenylamine (NMPA) above the acceptable limit. There will be no further production of Stemetil® 5mg/5ml Syrup, so this is in effect a product discontinuation and supplies are no longer available. Prochlorperazine tablets and buccal tablets, as well as alternative antiemetics (including some liquid options), remain available and can support a full uplift in demand.
Please refer to the Medicine Supply Notification on StaffNet for actions required by clinicians and supporting information on therapeutic alternatives.
Why do medicine shortages occur?
Medicine shortages occur for a variety of reasons, including difficulties sourcing raw materials, product recalls for safety reasons, changes to licence holder, and changes to pack sizes.
It is vitally important that medicine shortages are monitored and appropriate actions taken, to minimise impact on patient care.
Where can I find further advice and information on medicine supply problems and shortages?
For the most up-to-date advice and information please refer to Current Medicine Supply Problems and Shortages page on StaffNet.
Published 02/11/2022. Medicines Update blogs are correct at the time of publication.